This is a working overview of research chemical, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-04-09 and is reviewed periodically as new material appears.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common supplier description |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water |
| Typical storage | −20 °C, desiccated, dark | For research samples |
| Analytical method | LC-MS/MS | Used for detection and quantification |
| Regulatory status | Prohibited in sport | WADA metabolic modulator class |
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Parmotrema perlatum, commonly known as the powdered ruffle lichen, is a common species of foliose lichen in the family Parmeliaceae. The species has a cosmopolitan distribution and occurs throughout the Northern and Southern Hemispheres. Parmotrema perlatum is a prominent and widely recognised species within its genus across primarily temperate zones, preferring humid, oceanic-suboceanic habitats. It is found in diverse geographic areas including Africa, North and South America, Asia, Australasia, Europe, and islands in the Atlantic and Pacific oceans. It usually grows on bark, but occasionally occurs on siliceous rocks, often among mosses. The thallus of Parmotrema perlatum is large, light-grey to pale-blue patch-shaped with rounded and ruffled lobes and often with black hair-cilia at the edges. Distinguishing features of the lichen include its conspicuous soralia (reproductive structures) near the lobe edges, curled leaf-like lobes, and a narrow, shiny, and sometimes wrinkly area on the underside near the margin. This species is known for producing certain secondary metabolites, namely atranorin and a group of substances known as the stictic acid complex, which includes stictic and constictic acids, among other related compounds. These morphological and chemical characteristics help distinguish P. perlatum from several other potential lookalikes. Parmotrema perlatum has a complex taxonomic history, having undergone multiple reclassifications since its original description in 1762.
==== Brazil ==== Working on public policies, Brazil hosts, for example, Instituto Liberdade, a University-based Center at Tecnopuc inside the Pontifícia Universidade Católica do Rio Grande do Sul, located in the South Region of the country, in the city of Porto Alegre. Instituto Liberdade is among the Top 40 think tanks in Latin America and the Caribbean, according to the 2009 Global Go To Think Tanks Index a report from the University of Pennsylvania's Think Tanks and Civil Societies Program (TTCSP). Fundação Getulio Vargas (Getulio Vargas Foundation (FGV)) is a Brazilian higher education institution. Its original goal was to train people for the country's public- and private-sector management. Today it hosts faculties (Law, Business, Economics, Social Sciences and Mathematics), libraries, and also research centers in Rio, São Paulo and Brasilia. It is considered by Foreign Policy magazine to be a top-five "policymaker think tank" worldwide. The Igarapé Institute is a Brazilian think tank focusing on public, climate, and digital security.
==== Productivity loss ==== The estimated loss of human capital and productivity due to labor absenteeism in 2003 amounted to $366.2 billion. On the other hand, the loss of land productivity, which translates into a negative impact on administration, investment in physical and social capital, and the price of land in subsectors such as livestock and commercial agriculture is one of the consequences associated with the presence of an armed conflict. This cost is mainly assumed by farmers who experience the pressure of armed actions in their areas of operation. Within this context, the most serious consequences are related to the devaluation of the properties, the loss of productivity of the land (represented in the products that could potentially have been cultivated in these lands), and the difficulty in managing the efficient production of the lands. According to a study of National Planning, between 1999 and 2003 the estimated costs for the loss of productivity of land represented $140,443.5 million, equivalent to 1.28% of the GDP of the agricultural sector of 2003.
Sources: en.wikipedia.org
===== Phase I ===== During phase I metabolism, mitragynine undergoes hydrolysis of the methylester group on C16 as well as o-demethylation of both methoxy groups on positions 9 and 17. Following this step, oxidation and reduction reactions convert aldehyde intermediates into alcohols and carboxylic acids. P450 metabolic enzymes are known to facilitate the phase I metabolism of mitragynine which reportedly has an inhibitory effect on multiple P450 enzymes, raising the possibility of adverse drug interactions.
Brazil's international relations are based on Article 4 of the Federal Constitution, which establishes non-intervention, self-determination, international cooperation and the peaceful settlement of conflicts as the guiding principles of Brazil's relationship with other countries and multilateral organizations. According to the constitution, the president has ultimate authority over foreign policy, while Congress is tasked with reviewing and considering all diplomatic nominations and international treaties, as well as legislation relating to Brazilian foreign policy. Brazil's foreign policy is a by-product of the country's position as a regional power in Latin America, a leader among developing countries, and an emerging world power. Brazilian foreign policy has generally been based on the principles of multilateralism, peaceful dispute settlement, and non-intervention in the affairs of other countries. Brazil is a founding member state of the Community of Portuguese Language Countries (CPLP), also known as the Lusophone Commonwealth, an international organization and political association of Lusophone nations. An increasingly well-developed tool of Brazil's foreign policy is providing aid as a donor to other developing countries. Brazil does not just use its growing economic strength to provide financial aid, but it also provides high levels of expertise and most importantly of all, a quiet non-confrontational diplomacy to improve governance levels. Total aid is estimated to be around $1 billion per year.
=== Maternal body mass index === Maternal body mass index (BMI) is an important predictor of childhood obesity. Mothers with pre-pregnancy obesity, as defined by BMI ≥30 kg/m2, are known to have children that have higher growth rates and more likely to have obesity.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.
Detection commonly uses liquid chromatography–tandem mass spectrometry. This method can identify the compound in urine or blood at low concentrations.
Typical guidance is −20 °C, dry, and protected from light. Solutions should be aliquoted and limited freeze–thaw cycles should be used.
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.